NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Exco InTouch's Electronic Patient Diary Selected by Synairgen to Capture ePRO Data - Exco InTouch's Electronic Patient Diary selected by Synairgen to capture ePRO data in IFN-beta Asthma trial
Exco InTouch's Electronic Patient Diary Selected by Synairgen to Capture ePRO Data

 

NewswireTODAY - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2008/09/30 - Exco InTouch's Electronic Patient Diary selected by Synairgen to capture ePRO data in IFN-beta Asthma trial.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Exco InTouch, the leading mobile messaging provider for the pharmaceutical industry, announces that its electronic patient reported outcomes (ePRO) solutions have been selected by Synairgen, a drug discovery company focused on asthma and chronic obstructive pulmonary disease (COPD).
Exco InTouch's short message service (SMS) ePRO offerings will enable Synairgen to collect patient data in its second clinical study of inhaled interferon beta (IFN-beta) for asthma treatment.

This Phase 1 study from Synairgen is designed to establish the safety of inhaled IFN-beta at four different dose levels over a 14 day period in asthmatic volunteers. Exco InTouch's innovative text messaging ePRO system will enable Synairgen to collect accurate PRO data which might be crucial in gauging the efficacy in future studies.

Using secure mobile online access, this technology will allow patients to complete diary questionnaires at pre-specified times via a series of text messages. Secure text messages will enable Synairgen's patients to easily record and transmit data concerning their asthma using their own mobile phone, facilitating diary data collection which is then relayed back to the clinical sites for further analyses.

"Symptom diary cards are notoriously unreliable; we are attracted to this simple method for collecting asthma symptom scores on a daily basis" said Richard Marsden, Managing Director of Synairgen

About Exco InTouch's ePRO Solutions
For more complex data collection, a java application which runs on the patient's own mobile phone can be used in mobile data capture, dose titration and disease exacerbation monitoring. Simple and easy to deploy, Exco InTouch's software can be used for daily questionnaires in conjunction with the REACT compliance platform to deliver high quality data within appropriate timeframes.

For further press information please contact: Eleanor CallanMonk, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA T: +44 1477 539539 F: +44 1477 539540 E: exco[.]scottpr.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Exco InTouch's Electronic Patient Diary Selected by Synairgen to Capture ePRO Data

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Eleanor CallanMonk 
+44(0)14 7753 9539 exco[.]scottpr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Withings Launches Withings Medical, Bringing Clinical Care to Medicare-Eligible Patients Under CMS's New ACCESS Model
Bruker Launches D8 ADVANCE HE and D8 DISCOVER HE High-Energy XRD Systems for Batteries, Amorphous Materials, and Catalysts
Withings Acquires Biosency and Enters Respiratory Remote Monitoring
Bruker Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
Institut Curie, the CEA and Thales Sign a Partnership to Build a Unique FLASH Radiotherapy Platform to Accelerate the Cure for Cancers
Royal Healthcare in Singapore Provides NEC's 'FonesVisuas Test' for Disease Risk Prediction
Bruker Showcases Analytical and Automation Innovations for Applied, Biopharma, Industrial and Academic Markets At Analytica 2026
Bruker Showcases Extended Automation in Biophysics SLAS2026
SCHOTT Pharma Polymer Cartridge Platform Compatible with Large-volume SHL Medical Autoinjectors
OctoNerv Announces Completion of the First Functional Prototype of the Electronic Breast Nipple Implant (EBNI)
Birmingham’s National NMR Hub Advances UK Biomolecular and Solid-State Research with World-Leading NMR Technology
Bruker Launches The VERTEX NEO Ultra
Bruker Launches xView Module for Ultima 2Pplus Multiphoton Microscopes
LANXESS Presents its Disinfection Portfolio for the First Time At Medica 2025
Bruker Announces Advancements in Immunopeptidomics, de novo PTM Analysis, and Proteoform Profiling

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Limelon Advertising, Co.





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)